|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.04 CAD | 0.00% |
|
0.00% | -27.27% |
| 29/03 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
| 19/03 | RAMM Pharma Corp. cancelled the transaction announced on September 5, 2023 | CI |
RAMM Pharma Corp. reported earnings results for the full year ended October 31, 2022. For the full year, the company reported sales was CAD 3.9 million compared to CAD 4.12 million a year ago.
Net loss was CAD 20.96 million compared to CAD 7.11 million a year ago. Basic loss per share from continuing operations was CAD 0.1707 compared to CAD 0.0655 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.27% | 3.51M | |
| +33.63% | 50.85B | |
| -0.09% | 42.82B | |
| +49.62% | 42.03B | |
| -4.96% | 29.55B | |
| +11.18% | 26.11B | |
| -21.95% | 19.13B | |
| +8.61% | 13.05B | |
| +28.31% | 12.16B | |
| +24.73% | 12.08B |
RAMM PHARMA CORP. 